1. Home
  2. RCEL vs PLBY Comparison

RCEL vs PLBY Comparison

Compare RCEL & PLBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • PLBY
  • Stock Information
  • Founded
  • RCEL N/A
  • PLBY 1953
  • Country
  • RCEL United States
  • PLBY United States
  • Employees
  • RCEL N/A
  • PLBY N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • PLBY Recreational Games/Products/Toys
  • Sector
  • RCEL Health Care
  • PLBY Consumer Discretionary
  • Exchange
  • RCEL Nasdaq
  • PLBY Nasdaq
  • Market Cap
  • RCEL 161.5M
  • PLBY 138.1M
  • IPO Year
  • RCEL N/A
  • PLBY N/A
  • Fundamental
  • Price
  • RCEL $5.32
  • PLBY $1.56
  • Analyst Decision
  • RCEL Strong Buy
  • PLBY Hold
  • Analyst Count
  • RCEL 4
  • PLBY 1
  • Target Price
  • RCEL $16.50
  • PLBY $0.70
  • AVG Volume (30 Days)
  • RCEL 326.4K
  • PLBY 355.4K
  • Earning Date
  • RCEL 08-07-2025
  • PLBY 08-07-2025
  • Dividend Yield
  • RCEL N/A
  • PLBY N/A
  • EPS Growth
  • RCEL N/A
  • PLBY N/A
  • EPS
  • RCEL N/A
  • PLBY N/A
  • Revenue
  • RCEL $71,661,000.00
  • PLBY $116,691,000.00
  • Revenue This Year
  • RCEL $57.16
  • PLBY $3.96
  • Revenue Next Year
  • RCEL $36.69
  • PLBY $1.75
  • P/E Ratio
  • RCEL N/A
  • PLBY N/A
  • Revenue Growth
  • RCEL 41.35
  • PLBY N/A
  • 52 Week Low
  • RCEL $4.71
  • PLBY $0.52
  • 52 Week High
  • RCEL $14.16
  • PLBY $2.44
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 39.85
  • PLBY 56.68
  • Support Level
  • RCEL $4.71
  • PLBY $1.41
  • Resistance Level
  • RCEL $5.55
  • PLBY $1.73
  • Average True Range (ATR)
  • RCEL 0.29
  • PLBY 0.08
  • MACD
  • RCEL 0.08
  • PLBY 0.00
  • Stochastic Oscillator
  • RCEL 41.03
  • PLBY 54.71

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About PLBY PLBY Group Inc.

PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.

Share on Social Networks: